BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Iroko Pharmaceuticals 



Philadelphia  Pennsylvania    U.S.A.
Phone: Fax:


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Iroko Pharmaceuticals Release: New Long-Term Safety And Quality Of Life Data Reported For ZORVOLEX® In Osteoarthritis Patients 11/17/2014 4:36:48 PM
Iroko Pharmaceuticals To Present New ZORVOLEX® Osteoarthritis Data At American College of Rheumatology 2014 Annual Meeting 11/3/2014 10:03:30 AM
Iroko Pharmaceuticals Announces New Strategic Agreement To Commercialize ZORVOLEX® In Australia And New Zealand 10/28/2014 9:15:50 AM
Iroko Pharmaceuticals Signs New Strategic Agreement With Landsteiner Scientific To Bring ZORVOLEX® To Mexico 10/21/2014 7:04:28 AM
Iroko Pharmaceuticals Announces Inclusion Of ZORVOLEX® In Key 2015 National Formularies 9/3/2014 11:02:54 AM
Iroko Pharmaceuticals Gains FDA Approval Of ZORVOLEX® For Management Of Osteoarthritis Pain 8/25/2014 8:13:26 AM
Iroko Pharmaceuticals Continues To Expand Commercialization Of ZORVOLEX Ex-US 7/22/2014 7:50:13 AM
Iroko Pharmaceuticals Announces New Strategic Agreement To Commercialize ZORVOLEX® In Brazil 7/15/2014 7:47:16 AM
Iroko Pharmaceuticals Announces First International Filing for ZORVOLEX® 7/8/2014 6:59:46 AM
Iroko Pharmaceuticals Release: SoluMatrix® Meloxicam Demonstrates Significant Efficacy At 30 Percent Lower Doses In The Treatment Of Osteoarthritis 6/12/2014 9:40:19 AM
1234567